Sites will be able to easily access systems from multiple sponsors and studios to increase efficiency and speed.
BARCELONA, Spain, Sept. 13, 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced Veeva Study Portal, a free cloud application to simplify research site access to sponsoring technologies. Study Portal will make it easier for clinical investigators to create and share study profiles containing links to all relevant sponsoring technology systems used for a clinical trial. Users will be able to securely store their individual usernames and passwords with the study profile instead of managing multiple links, usernames and passwords on sticky notes or spreadsheets. Study Portal will work with all sponsor technology systems.
In addition to Study Portal, Veeva announced VeevaID to provide single sign-on for clinical investigators across all sponsoring systems, such as Veeva Vault EDC, Veeva Vault Study Training, and Veeva RTSM. When sponsors use Veeva technology and enable VeevaID, the access links in the Study Portal will take the user directly to the corresponding study screen through single sign-on without requiring an additional username or password.
“Research sites are focused on patient care, so alleviating the administrative burden of managing large lists of credentials between studies and partners is not a luxury but a necessity,” said principal investigator Dr. Vivënne van de Walle. and PT Medical Director
VeevaID will also be open to Veeva partners who join the VeevaID partner program, meet security standards, and have integrated VeevaID technology. The program will allow third-party providers to authenticate using VeevaID to directly log into the system through the Study Portal.
Veeva Study Portal and VeevaID are planned to be available in December 2023. Veeva provides free technology solutions to research sites as part of its mission as a Public Benefit Corporation (PBC). Learn more about Veeva Study Portal at studyportal.veeva.com.
Additional Information: For more information about Veeva solutions, visit sites.veeva.com
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world’s largest biopharmaceutical companies to emerging biotech companies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders and the industries it serves. For more information, visit veeva.com/eu.
Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva’s products and services and the expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we undertake no obligation to update such statements. There are numerous risks that could adversely affect our results, including the risks and uncertainties set forth in our Form 10-Q filing for the period ended July 31, 2023, which can be found here (a summary is on pages 38 and 39). of risks that may affect our business), and in our subsequent filings with the SEC, which can be accessed at sec.gov.
Logo – https://mma.prnewswire.com/media/1488285…
View original content: https://www.prnewswire.com/news-releases/veeva-presenta-study-portal-y-veevaid-para-agilizar-la-ejecucion-de-pruebas-en-el-sitio-de-investigacion-301926653.html
